CXCL12 and Miyoshi myopathy: It was also reported that the anti-PD-1 antibody increased chemotaxis through the SDF-1/CXCR4 axis, resulting in the enhancement of NK cell-mediated cytotoxicity against MM cells [43,44], and those results support the reasonable combination of anti-PD-1 and IMiDs.